Trials / Completed
CompletedNCT04688580
Pharmacokinetics, Safety, and Tolerability of Various XW10172 Oral Formulations in Healthy Adult Volunteers
An Open-label, Crossover Study to Assess the Pharmacokinetics, Safety, and Tolerability of Various XW10172 Oral Immediate- and Modified-release Formulations in Healthy Adult Volunteers
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 46 (actual)
- Sponsor
- XWPharma · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of the study is to evaluate the safety, tolerability and pharmacokinetics of various formulations of XW10172 in healthy volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | XW10172 | Various formulations |
Timeline
- Start date
- 2020-11-29
- Primary completion
- 2021-12-14
- Completion
- 2021-12-14
- First posted
- 2020-12-30
- Last updated
- 2022-11-04
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT04688580. Inclusion in this directory is not an endorsement.